SCOTTIE SMITH: Open Payments
NPI 1386048866 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,288 in 81 payments from 12 companies in 2025. Trend: 2023 $1,579 · 2024 $1,637 · 2025 $1,288
Food & beverage: $1,288
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $505 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $269 |
| Lilly USA, LLC | 8 | $153 |
| Phathom Pharmaceuticals, Inc. | 8 | $76 |
| Janssen Biotech, Inc. | 4 | $66 |
| Aimmune Therapeutics, Inc. | 3 | $62 |
| GENZYME CORPORATION | 2 | $41 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Celltrion USA Inc. | 1 | $26 |
| QOL Medical, LLC | 1 | $24 |
Products named: RINVOQ, ENTYVIO, SKYRIZI, OMVOH, VOQUEZNA, MAVYRET, TREMFYA, ZENPEP.
Industry payments across OK — which companies pay providers there.
